Guideline Recommendations for Diagnosis and Management of Intraventricular Conduction Delay

Diagnostic Evaluation

Obtain a 12‑lead electrocardiogram to classify the specific intraventricular conduction pattern (complete RBBB, complete LBBB, or nonspecific IVCD), as this classification determines all subsequent therapeutic decisions. 3
Complete right‑bundle‑branch block (RBBB): QRS ≥ 120 ms with an rsr′ pattern in V1‑V2 and an S wave > 40 ms in leads I and V6. 1
Complete left‑bundle‑branch block (LBBB): QRS ≥ 120 ms with broad, notched R waves in I, aVL, V5‑V6, absent Q waves in I, V5‑V6, and an R‑peak time > 60 ms in V5‑V6. 1
Nonspecific intraventricular conduction delay (IVCD): QRS > 110 ms without meeting RBBB or LBBB morphological criteria. 1
Perform transthoracic echocardiography in every patient with a newly identified conduction abnormality to detect underlying structural heart disease or left‑ventricular systolic dysfunction. 3

Do not implant a permanent pacemaker in asymptomatic individuals with isolated bundle‑branch block and 1:1 AV conduction (Class III: Harm). 1
Continue beta‑blocker therapy when the resting heart rate remains >55 bpm. 2
Arrange regular clinical follow‑up because IVCD can be an early marker for future coronary artery disease and heart‑failure development. 3
Apply a lower threshold for cardiac imaging or functional testing in patients with LBBB compared with other conduction patterns. 3

Use ambulatory electrocardiographic monitoring to correlate light‑headedness, dizziness, or syncope with rhythm disturbances (American College of Cardiology). 4
Consider exercise treadmill testing for exertional symptoms in patients who exhibit first‑degree or Mobitz I (Wenckebach) AV block at rest (American College of Cardiology). 4
Implant a permanent pacemaker for acquired second‑degree Mobitz II AV block, high‑grade AV block, or third‑degree AV block not attributable to reversible causes (Class I, American College of Cardiology). 4
Pacemaker implantation is also indicated for syncope with bundle‑branch block and an HV interval ≥ 70 ms or documented infranodal block on electrophysiology study (Class IIa). 3
Alternating bundle‑branch block signifies a high risk of progression to complete heart block and warrants pacing (Class IIa). 3
Marked first‑degree or second‑degree Mobitz I AV block accompanied by symptoms clearly attributable to the block should be managed with pacing (Class IIa, American College of Cardiology). 4

Cardiac resynchronization therapy (CRT) is recommended for patients with true LBBB, QRS duration ≥ 150 ms, left‑ventricular ejection fraction ≤ 35 %, and NYHA class II–IV symptoms despite optimal medical therapy (Class I). (American College of Cardiology). 3
CRT may be considered in non‑LBBB morphologies when QRS duration ≥ 150 ms, although the supporting evidence is weaker (Class IIb). 3
Optimize guideline‑directed medical therapy concurrently, including ACE inhibitors or ARBs, beta‑blockers, mineralocorticoid‑receptor antagonists, and diuretics for volume management (Class I). 1
Avoid calcium‑channel blockers and anti‑arrhythmic agents that can exacerbate heart failure (Class III). 1

Administer atropine as first‑line therapy for AV‑nodal‑level block (Class IIa). (American College of Cardiology). 1
Do not use atropine in patients with infranodal conduction disease, as it may worsen the block. (American College of Cardiology). 2
Initiate temporary transvenous pacing for bradyarrhythmias refractory to medical therapy (Class IIa). 2
Defer permanent pacemaker implantation for at least 72 hours after myocardial infarction because conduction abnormalities often resolve with reperfusion. (Class III). 2
After the observation period, implant a permanent pacemaker for persistent second‑degree Mobitz II, high‑grade AV block, alternating bundle‑branch block, or third‑degree AV block post‑MI (Class I). 3
Permanent pacing is not indicated for transient AV block that resolves or for isolated new bundle‑branch or fascicular block without higher‑degree AV block. (Class III). 3

Neuromuscular diseases: Implant a permanent pacemaker with defibrillator capability (when expected survival > 1 year) for muscular dystrophy or Kearns‑Sayre syndrome patients with second‑degree or third‑degree AV block, or an HV interval ≥ 70 ms (Class I, American College of Cardiology). 4
For lamin A/C gene mutations presenting with PR interval > 240 ms and LBBB, pacing with defibrillator capability is reasonable (Class IIa). (American College of Cardiology). 4
In myotonic dystrophy type 1, pacing with defibrillator capability is reasonable when PR > 240 ms, QRS > 120 ms, or fascicular block is present (Class IIb). (American College of Cardiology). 4
Infiltrative cardiomyopathies (cardiac sarcoidosis or amyloidosis) with second‑degree Mobitz II, high‑grade, or third‑degree AV block, permanent pacing with defibrillator capability is reasonable (Class IIa). (American College of Cardiology). 4
Athletes with QRS duration ≥ 140 ms should undergo echocardiography to exclude structural heart disease (Class IIa). 1
Patients with permanent atrial fibrillation and symptomatic bradycardia should receive a permanent pacemaker (Class I, American College of Cardiology). 4

Implanting a permanent pacemaker in an asymptomatic patient with isolated bundle‑branch block and 1:1 AV conduction provides no benefit and may cause harm (Class III). 1
IVCD occurring after myocardial infarction often reflects extensive myocardial injury and is associated with a poorer prognosis, especially in anterior infarctions (Class IIa). 3
Failure to consider QRS morphology (LBBB vs. non‑LBBB) and duration (≥150 ms vs. 120–149 ms) when selecting candidates for CRT markedly reduces the likelihood of a favorable response (Class IIa). 2
Permanent pacemaker implantation should be avoided within the first 72 hours after MI to allow time for possible resolution of conduction disturbances (Class III). 2
Do not dismiss IVCD as merely an electrical abnormality; it may be the first sign of underlying structural heart disease or cardiomyopathy and warrants further evaluation (Class IIa). 3